NCT06558305View on ClinicalTrials.gov

IL-6, IL-12, IL-15 and IL-23 Expression Levels in Rheumatoid Arthritis Patients

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

April 30, 2025

Conditions
Rheumatoid Arthritis
Interventions
OTHER

blood sample

Total RNA will be extracted from the whole blood using a commercial extraction kit (RNA Extraction Kit, applied biotechnology Co.Ltd, Egypt) according to the manufacturer's instructions. RNA will be stored at -80°C.The extracted RNA will be used for cDNA synthesis using commercial kits (cDNA Synthesis Kit, applied biotechnology Co.Ltd, Egypt), according to the manufacturer's instruction.

All Listed Sponsors
lead

Assiut University

OTHER

NCT06558305 - IL-6, IL-12, IL-15 and IL-23 Expression Levels in Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter